NO942813L - Spröytekjölt nabumeton - Google Patents

Spröytekjölt nabumeton

Info

Publication number
NO942813L
NO942813L NO942813A NO942813A NO942813L NO 942813 L NO942813 L NO 942813L NO 942813 A NO942813 A NO 942813A NO 942813 A NO942813 A NO 942813A NO 942813 L NO942813 L NO 942813L
Authority
NO
Norway
Prior art keywords
pct
spray
nabumeton
peeled
sec
Prior art date
Application number
NO942813A
Other languages
English (en)
Other versions
NO942813D0 (no
Inventor
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO942813L publication Critical patent/NO942813L/no
Publication of NO942813D0 publication Critical patent/NO942813D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Nabumeton som er sprøytekjølt og formulert til enhetsdose-former som har et mindre volum enn det som tidligere var mulig.
NO942813A 1992-01-29 1994-07-28 Spröytekjölt nabumeton NO942813D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201857A GB9201857D0 (en) 1992-01-29 1992-01-29 Novel compound
PCT/GB1993/000145 WO1993014747A1 (en) 1992-01-29 1993-01-22 Spray-chilled nabumetone

Publications (2)

Publication Number Publication Date
NO942813L true NO942813L (no) 1994-07-28
NO942813D0 NO942813D0 (no) 1994-07-28

Family

ID=10709436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942813A NO942813D0 (no) 1992-01-29 1994-07-28 Spröytekjölt nabumeton

Country Status (24)

Country Link
US (1) US5539000A (no)
EP (1) EP0624087B1 (no)
JP (1) JPH07503245A (no)
KR (1) KR950700056A (no)
CN (1) CN1079954A (no)
AT (1) ATE150298T1 (no)
AU (1) AU3362693A (no)
BG (1) BG98933A (no)
BR (1) BR9305674A (no)
CA (1) CA2129027A1 (no)
CZ (1) CZ182894A3 (no)
DE (1) DE69309037T2 (no)
DK (1) DK0624087T3 (no)
ES (1) ES2099419T3 (no)
FI (1) FI943550A (no)
GB (1) GB9201857D0 (no)
GR (1) GR3023142T3 (no)
HU (1) HUT67462A (no)
IL (1) IL104526A0 (no)
MX (1) MX9300430A (no)
NO (1) NO942813D0 (no)
SK (1) SK91694A3 (no)
WO (1) WO1993014747A1 (no)
ZA (1) ZA93577B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB9920148D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel composition
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
CA2547773A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053655A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
WO2005053656A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
RU2006119453A (ru) * 2003-12-04 2007-12-20 Пфайзер Продактс Инк. (Us) Получение посредством основанных на применении жидкостей способов лекарственные формы азитромицина с большим количеством частиц
WO2006044657A2 (en) * 2004-10-15 2006-04-27 Altairnano, Inc. Phosphate binder with reduced pill burden
EP1928349A4 (en) * 2005-08-17 2008-10-01 Altairnano Inc COMPOSITIONS AND METHODS FOR TREATING CHRONIC RENAL FAILURE AND OTHER CONDITIONS IN DOMESTIC ANIMALS
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) * 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US8961917B2 (en) 2010-05-12 2015-02-24 Spectrum Pharmaceuticals, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474377A (en) 1973-09-11 1977-05-25 Beecham Group Ltd Naphthalene derivatives
US4420639C1 (en) * 1973-09-11 2001-08-21 Beecham Group Ltd Aromatic compounds
US4086346A (en) * 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
DE3833446A1 (de) 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Also Published As

Publication number Publication date
DE69309037T2 (de) 1997-07-24
MX9300430A (es) 1994-08-31
EP0624087A1 (en) 1994-11-17
DE69309037D1 (de) 1997-04-24
WO1993014747A1 (en) 1993-08-05
GR3023142T3 (en) 1997-07-30
AU3362693A (en) 1993-09-01
IL104526A0 (en) 1993-05-13
US5539000A (en) 1996-07-23
FI943550A0 (fi) 1994-07-28
ES2099419T3 (es) 1997-05-16
KR950700056A (ko) 1995-01-16
CN1079954A (zh) 1993-12-29
CZ182894A3 (en) 1995-02-15
BG98933A (en) 1995-07-28
NO942813D0 (no) 1994-07-28
HUT67462A (en) 1995-04-28
SK91694A3 (en) 1995-03-08
BR9305674A (pt) 2005-01-11
ZA93577B (en) 1994-01-13
JPH07503245A (ja) 1995-04-06
CA2129027A1 (en) 1993-08-05
DK0624087T3 (da) 1997-09-01
ATE150298T1 (de) 1997-04-15
FI943550A (fi) 1994-07-28
HU9402221D0 (en) 1994-09-28
GB9201857D0 (en) 1992-03-18
EP0624087B1 (en) 1997-03-19

Similar Documents

Publication Publication Date Title
NO942813L (no) Spröytekjölt nabumeton
EP0602790A3 (en) Directing operation of computer systems.
FR2689717B1 (fr) Dispositif d'application de micro-ondes et reacteur a plasma utilisant ce dispositif.
PH31249A (en) Inhibitors of hiv protease.
IL99214A0 (en) Hypoglycemic hydroxyurea derivatives
NO982567D0 (no) Forbedret hydrogenolyse av 2,4,6,8,10,12-heksaazatetracyklo (5.5.0.05.903.11) dodekan
NZ312327A (en) Controlling hemipteran insect pests with bacillus thuringiensis
FI942313A0 (fi) Välituote atsitromysiiniä varten
HUT64204A (en) Method and tool for dosing liquid product
CA2100589A1 (en) Method for specifying user interfaces and programming system running a multiple user interface type computer
ZA968894B (en) Hydroformylation process of ethylenically unsaturated compounds.
AU1102092A (en) Reducing the development of pale, soft and exudative pork
WO1996026728A3 (en) Use of moxonidine for the treatment of atherosclerosis
AU7962091A (en) Phenyl 4-guanidinobenzoate derivative, process for producing the same, and protease inhibitor containing the same
TW342311B (en) Fungicidal mixtures
ZA936861B (en) Methods and agents for combating cockroaches.
ES2145125T3 (es) Disposicion de proteccion de conmutador.
RU1809521C (ru) Генератор плазмы
US5647301A (en) Method for planting fish eggs and a planting tube for carrying out the method
EP0646373A3 (en) Epstein-Barr virus expression inhibitor.
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
AP9200409A0 (en) Sasakwa gari processor.
EP0799176A4 (en) 4.4- (DISUBSTITUTED) CYCLOHEXAN-1-ONE DIMERS AND RELATED COMPOUNDS
ES1021888Y (es) Manguera contra incendios.
KR960003469U (ko) 브라운관의 이.엠.아이(emi) 차단장치